LNTH Lantheus Holdings Earnings and EPS analysis

  1. Stocks
  2. Healthcare
  3. NASDAQ: LNTH
  4. Earnings
?
Relative Growth: Rel. Growth: 64
Relative Strength: Rel. Strength: 85
Relative Valuation: Rel. Valuation: 46
Relative Profitability: Rel. Profitability: 83

EPS in 2026 (TTM): $4.22

Last Report Period Date: Jun 30, 2026

Currently, LNTH's 12-month EPS stands at $4.22, according to the most recent financial reports. During 2025, LNTH reported a per-share earnings of $3.46, which shows a decline compared to the EPS of $4.52 recorded in 2024. LNTH recorded an EPS of $1.15 for the quarterly period ending on Jun 30, 2026.

LNTH earnings history

Historical annual and quarterly earnings per share (EPS) data for Lantheus Holdings
EPS (TTM)
$4.22
EPS Growth YoY (Quarterly)
0%
EPS (Quarterly)
$1.15
EPS Growth (Quarterly)
-37.2%

In 2025, Lantheus Holdings's earnings per share was $3.46, a decline of 23.5% from $4.52 in 2024. Over the quarter ending Jun 30, 2026, the earnings per share came in at $1.15, reflecting no change compared to the same quarter last year. As of June 2026, the TTM EPS is $4.22. During 2024, the annual earnings per share was $4.52, representing a decrease of 5.6% compared to 2023.

LNTH EPS vs price chart

LNTH EPS growth history

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
0%
EPS growth YoY
-23.5%
EPS growth 3Y avg
103.6%
EPS growth 5Y avg
N/A

Lantheus Holdings has recorded no change in earnings per share over the past 12 months (YoY, quarterly). During the past three years, LNTH registered an average yearly EPS growth of 103.6%.

LNTH Earnings Waterfall

Breakdown of revenue, profit and net income for Lantheus Holdings

LNTH Earnings vs Peers

What are the earnings of LNTH compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
LNTH Lantheus Holdings Inc 23.69 -23.5% 103.6% N/A
ABT Abbott Laboratories 33.38 -51.4% -1.8% 8.2%
IDXX Idexx Laboratories Inc 36.43 22.3% 17.5% 14.1%
CTSO Cytosorbents Corp N/A 65.8% N/A N/A

All data is based on quarterly TTM periods, unless otherwise specified.